EndoSound’s Vision System, a platform whose transducer transforms a conventional upper endoscope into a fully functional endoscopic ultrasound device, received FDA breakthrough device designation in July 2021, according to a Jan. 24 news release from the company. The platform has not been cleared by the FDA.
EndoSound will use the funding to improve Vision System’s access, reduce cost and increase safety, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
